Shares of CSL Limited (OTCMKTS:CSLLY – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $83.31 and last traded at $86.54, with a volume of 75792 shares changing hands. The stock had previously closed at $86.47.
CSL Stock Up 0.1 %
The stock’s fifty day moving average is $92.75 and its 200-day moving average is $97.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97.
About CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Read More
- Five stocks we like better than CSL
- What is a buyback in stocks? A comprehensive guide for investors
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Most Volatile Stocks, What Investors Need to Know
- CarMax Gets in Gear: Is Now the Time to Buy?
- How to Calculate Return on Investment (ROI)
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
